WO2005046562A3 - Verwendung sulfatierter hyaluronsäure - Google Patents
Verwendung sulfatierter hyaluronsäure Download PDFInfo
- Publication number
- WO2005046562A3 WO2005046562A3 PCT/EP2004/012225 EP2004012225W WO2005046562A3 WO 2005046562 A3 WO2005046562 A3 WO 2005046562A3 EP 2004012225 W EP2004012225 W EP 2004012225W WO 2005046562 A3 WO2005046562 A3 WO 2005046562A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hyaluronic acid
- sulfated hyaluronic
- sulfated
- conjunctivitis
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04790993A EP1737412A2 (de) | 2003-11-04 | 2004-10-28 | Verwendung sulfatierter hyaluronsäure |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10352137.2 | 2003-11-04 | ||
DE10352137A DE10352137A1 (de) | 2003-11-04 | 2003-11-04 | Verwendung sulfatierter Hyaluronsäure |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005046562A2 WO2005046562A2 (de) | 2005-05-26 |
WO2005046562A3 true WO2005046562A3 (de) | 2008-12-11 |
Family
ID=34584931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2004/012225 WO2005046562A2 (de) | 2003-11-04 | 2004-10-28 | Verwendung sulfatierter hyaluronsäure |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1737412A2 (de) |
DE (1) | DE10352137A1 (de) |
WO (1) | WO2005046562A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009231634B2 (en) | 2008-04-04 | 2014-05-15 | University Of Utah Research Foundation | Alkylated semi-synthetic glycosaminoglycosan ethers, and methods for making and using thereof |
US8343942B2 (en) * | 2008-04-04 | 2013-01-01 | University Of Utah Research Foundation | Methods for treating interstitial cystitis |
IT1397247B1 (it) * | 2009-05-14 | 2013-01-04 | Fidia Farmaceutici | Nuovi agenti regolatori dell'attivita' citochinica |
US20130209531A1 (en) | 2010-06-08 | 2013-08-15 | University Of Utah Research Foundation | Applications of partially and fully sulfated hyaluronan |
WO2012129461A1 (en) | 2011-03-23 | 2012-09-27 | University Of Utah Research Foundation | Methods for treating or preventing urological inflammation |
EP2664330A1 (de) * | 2012-05-15 | 2013-11-20 | F. Holzer GmbH | Zusammensetzung und Arzneimittel enthaltend Omega-3-Fettsäuren sowie einen Glucosaminoglucan |
PT2898888T (pt) | 2014-01-22 | 2019-07-16 | Visufarma B V | Composição que compreende iota-carragenina contra conjuntivite viral |
US11337994B2 (en) | 2016-09-15 | 2022-05-24 | University Of Utah Research Foundation | In situ gelling compositions for the treatment or prevention of inflammation and tissue damage |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4240163A (en) * | 1979-01-31 | 1980-12-23 | Galin Miles A | Medicament coated intraocular lens |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079236A (en) | 1987-05-27 | 1992-01-07 | Hyal Pharmaceutical Corporation | Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use |
ITPD940054A1 (it) * | 1994-03-23 | 1995-09-23 | Fidia Advanced Biopolymers Srl | Polisaccaridi solfatati |
JPH08277224A (ja) | 1995-02-07 | 1996-10-22 | Shiseido Co Ltd | 抗炎症剤 |
US6579978B1 (en) | 1997-04-04 | 2003-06-17 | Fidia Farmaceuti S.P.A. | Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof |
ITPD980037A1 (it) | 1998-02-25 | 1999-08-25 | Fidia Advanced Biopolymers Srl | Acido ialuronico solfatato e i suoi derivati legati covalentemente a polimeri sintetici pe la preparazione di biomateriali e per il rivesti |
DE19813234A1 (de) | 1998-03-26 | 1999-09-30 | Knoell Hans Forschung Ev | Verfahren zur Herstellung hochsulfatierter Hyaluronsäuren |
DE59906391D1 (de) | 1998-12-23 | 2003-08-28 | Esparma Gmbh | Mittel zum schutz der haut enthaltend hydrolysierte hyaluronsäure |
DE10053866A1 (de) * | 2000-10-27 | 2002-05-08 | Condomi Erfurt Produktions Gmb | Bioverträgliche Flüssigformulierungen für human- und veterinärmedizinische Anwendungen als Gleitmittel |
DE10111165A1 (de) * | 2001-03-02 | 2002-10-10 | Knoell Hans Forschung Ev | Verwendung von Hyaluronsäure-Uroniden zur Behandlung von entzündlichen Vorgängen |
-
2003
- 2003-11-04 DE DE10352137A patent/DE10352137A1/de not_active Ceased
-
2004
- 2004-10-28 EP EP04790993A patent/EP1737412A2/de not_active Withdrawn
- 2004-10-28 WO PCT/EP2004/012225 patent/WO2005046562A2/de active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4240163A (en) * | 1979-01-31 | 1980-12-23 | Galin Miles A | Medicament coated intraocular lens |
Non-Patent Citations (2)
Title |
---|
CHANG N-S ET AL: "SYNTHETIC POLYSULFATED HYALURONIC ACID IS A POTENT INHIBITOR FOR TUMOR NECROSIS FACTOR PRODUCTION", JOURNAL OF LEUKOCYTE BIOLOGY, FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL, US, vol. 55, no. 6, 1 June 1994 (1994-06-01), pages 778 - 784, XP000568804, ISSN: 0741-5400 * |
See also references of EP1737412A2 * |
Also Published As
Publication number | Publication date |
---|---|
EP1737412A2 (de) | 2007-01-03 |
WO2005046562A2 (de) | 2005-05-26 |
DE10352137A1 (de) | 2005-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006073968A3 (en) | Derivatized 3,4-alkylenedioxythiophene monomers, methods of making them, and use thereof | |
WO2006026057A3 (en) | Short corridor progressive addition lenses with reduced unwanted astigmatism | |
WO2004080391A3 (en) | Novel antibacterial agents | |
WO2007092622A3 (en) | Compositions and methods for treating bone | |
WO2008064916A3 (de) | Mittel zur behandlung von vascular leaks | |
WO2006023649A3 (en) | Treatment of severe multiple sclerosis | |
WO2003093269A3 (de) | Substituierte pyrazolo-pyrimidin-4-one | |
WO2006072612A3 (en) | Triazolophthalazines as pde2- inhibitors | |
WO2005117938A3 (en) | Methods of treating ocular conditions | |
WO2006003492A3 (en) | Compositions and methods for treating pathological infections | |
WO2005005679A3 (en) | Super-hydrophobic surfaces, methods of their construction and uses therefor | |
BRPI0312331A2 (pt) | composições de ácido hialurônico e métodos de emprego. | |
UA85559C2 (en) | Aminobenzophenone compounds | |
WO2005039504A3 (en) | Compounds and methods for treating toll-like receptor 2-related diseases and conditions | |
WO2007053610A3 (en) | Methods of treating atrial fibrillation wtih pirfenidone | |
WO2002103103A3 (en) | Fluorine-containing compounds and polymers derived therefrom | |
UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
WO2005044093A3 (en) | Delta-9- the treatment of multiple sclerosis | |
WO2003002064A3 (en) | Fused pyrimidine dhfr inhibitors as antibacterials | |
WO2005044200A3 (en) | Methods and compositions for treating mcp-1 related pathologies | |
WO2004100890A3 (en) | Rage g82s-related methods and compositions for treating inflammatory disorders | |
WO2005046562A3 (de) | Verwendung sulfatierter hyaluronsäure | |
WO2005023191A3 (en) | Rage-related methods and compositions for treating glomerular injury | |
WO2004019879A8 (en) | Motilide compounds | |
WO2005001039A3 (en) | Ribozyme-regulated small inhibitory rna (sirna) production and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REEP | Request for entry into the european phase |
Ref document number: 2004790993 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004790993 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2004790993 Country of ref document: EP |